Kasow, K A <br/><br/>
A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up.  [electronic resource] 

 -  Bone marrow transplantation  Nov 2012 
 - 1448-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2012.51  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Neoplasms--drug therapy<br/>Risk Factors<br/>Survival Rate<br/>Topoisomerase I Inhibitors--administration & dosage<br/>Topotecan--administration & dosage<br/>Transplantation, Autologous